Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

As of 1:18:17 PM EST. Market Open. Why is RXRX moving today? Recursion Pharmaceuticals (RXRX) soared 9.35% after reporting a narrower-than-expected Q4 loss and a 35% revenue increase, significantly ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Abstract: Many modern object detectors demonstrate outstanding performances by using the mechanism of looking and thinking twice. In this paper, we explore this mechanism in the backbone design for ...